Mahima Datla: Last News

India's Biological E. to produce J&J Covid vaccine alongside its own candidate

NEW DELHI : India's Biological E. will produce the Johnson & Johnson COVID-19 vaccine alongside its own candidate, its managing director told Reuters on Tuesday, which could boost the country's overall supplies amid a shortage."The infrastructure and plants are completely separate for both the products and we will be producing both independent of each other," Mahima Datla said in a text message, declining to give any timeline or other detail.She told Reuters in February that Biological E.

was looking to contract-manufacture about 600 million doses of the J&J vaccine annually. India's government, however, did not factor in any production of J&J this year in the country in a list of likely vaccine output released last week.J&J said last month

. covid-19 vaccine Government

Mahima Datla